Search results
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be...
Motley Fool via Yahoo Finance· 2 days agoIt's not hard to see why the stock has fallen into penny-stock territory and is in danger of being...
23andMe CEO plans to take company private
MedTech Dive via Yahoo Finance· 7 days agoWojcicki's proposal as the new most likely outcome which should be welcomed by investors.” 23andMe has faced financial pressure as sales of DNA tests...
Nelson Peltz Got Crushed by Disney. Can He Recover?
The Wall Street Journal· 1 week agoNelson Peltz’s proxy fight at Disney had the potential to help turn around his hedge fund after a tumultuous stretch. Instead, the activist investor’s...
Aristotle Capital International Equity Q1 2024 Commentary
Seeking Alpha· 2 weeks agoAristotle Capital Management is an independent/employee-owned investment management organization...
Asthma Inhaler Chaos Leaves Us Doctors and the Children We Treat Out of Breath
US News & World Report· 7 days agoOn Jan. 10, Laura Goldstein went to her local Massachusetts pharmacy to fill her 4-year-old son’s prescription for Flovent, the go-to preventive asthma inhaler prescribed by pediatricians for ...
Asthma Attack: Allergies, Rising Costs Impacting Patients
WebMD· 1 week agoAcross the U.S., warmer days have beckoned an earlier spring, and with that, an earlier pollen season and worse seasonal allergies. Pair that with an ongoing respiratory virus season – particularly ...